Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial.
By H. Davies, Eleanor K. Mishra, B. Kahan, J. Wrightson, A. Stanton, A. Guhan, C. Davies, J. Grayez, R. Harrison, A. Prasad and 5 more. Journal of the American Medical Association (JAMA), 2012
629 citations recorded by the source corpus.
Subfields: Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/8a26b30a9154554753faadf9c0c5c3edb8cb7d1d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Critical Care and Intensive Care Medicine
In Pulmonary and Respiratory Medicine
In Surgery
Citations in the corpus
- Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018, background): “In case of a trapped lung by a thickened visceral pleural peel, indwelling pleural catheters or pleuroperitoneal shunts provide symptomatic relief [IV, B] [298, 299].”
- Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. (2013, methodology): “See TABLE 2: Example presentation of baseline PROs data in an RCT.(29) Explanation.”